Alternatives to NeuroICH

BrainSightAI is an innovative health technology firm that harnesses the power of artificial intelligence and machine learning to transform the field of brain mapping through AI-driven connectomics, allowing for the creation of customized brain maps. The VoxelBox product line employs these AI techniques to produce individualized brain maps tailored to each patient's needs. These advanced tools are specifically designed to facilitate pre-surgical preparation and enhance patient outcomes for those suffering from brain tumors and various neurological issues. Collaborating with top hospitals across the country, BrainSightAI is engaged in clinical trials that explore a range of brain-related ailments such as Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Committed to pushing the boundaries of brain science, our overarching goal is to improve quality of life by offering state-of-the-art resources that deepen our understanding of the human brain and its complexities. By continually refining our technology and methodologies, we aspire to make significant contributions to the medical community and the lives of patients.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

Developed by healthcare professionals for their peers, this technology aims to significantly enhance the quality of life for patients. Our AI-driven platform emphasizes speed, scalability, and security while offering the flexibility and customization that each hospital requires. It serves as a dependable long-term resolution. With RapidAI's stroke portfolio, you can expedite triage and transfer decisions with greater precision. Additionally, it facilitates the swift identification, monitoring, and proactive management of aneurysms. RapidAI's comprehensive suite of products for pulmonary embolism care enables quick detection of suspected PE cases. The AI-enhanced clinical decision support (CDS) software accelerates the decision-making process for physicians; however, it is crucial to recognize that not all AI solutions are equal. Only those CDS tools that possess clinical expertise can accurately identify, locate, characterize, and quantify suspected conditions. This advanced level of precision in AI-powered CDS modules contributes to improved triage and transfer decisions, ultimately leading to enhanced diagnostic accuracy and more efficient vascular care. By integrating these cutting-edge tools, healthcare providers can significantly elevate patient outcomes and operational efficiency.

Join AI is transforming the healthcare landscape with AI-powered tools designed to assist in radiology and endoscopy diagnostics. The platform offers AI-driven solutions for chest imaging, breast imaging, stroke detection, and gastrointestinal endoscopy, enabling clinicians to detect conditions like lung diseases, breast tumors, and gastrointestinal infections more efficiently. Join AI’s algorithms provide deeper insights, aiding in early diagnosis and faster decision-making, which are crucial for improving patient care and treatment outcomes. With seamless integration into existing workflows, the platform empowers healthcare professionals to make more confident decisions.

Apollo Medical Imaging Technology is a pioneering software company focused on enhancing medical imaging through innovative image processing solutions tailored for both clinical and research purposes. Their leading product, MIStar, stands out as a cost-effective and user-friendly software suite that encompasses a wide range of advanced features and versatile cross-modality solutions, catering to the needs of clinicians and original equipment manufacturers alike. MIStar efficiently accommodates several imaging modalities, including CT, MR, NM, and PET, and boasts specialized modules such as CT Perfusion for stroke and various tumors, DSC-MRI for stroke analysis, DCE-MRI for tumor assessments, as well as DWI & ADC, and DTI Fiber Tractography. Additionally, it offers NM Renogram Analysis and Image Fusion capabilities, making it a comprehensive tool in medical imaging. The software also ensures seamless data management and image input via DICOM networking, complemented by an intuitive clinical database that facilitates easy anonymization and archiving of sensitive patient data. This combination of features positions MIStar as a crucial asset in modern medical imaging practices.

Founded in 2016, Infervision stands at the forefront of AI-driven medical technology, dedicated to enhancing multidisciplinary healthcare services and operations through innovative artificial intelligence solutions. Their advanced AI offerings are designed to assist healthcare professionals across a spectrum of tasks, including disease screening, diagnosis, intervention, treatment, patient management, and medical research. Among their array of solutions, InferRead CT Lung specializes in detecting lung nodules from chest CT scans, while InferRead DR Chest focuses on identifying chest abnormalities via X-ray imaging. Moreover, InferRead CT Coronary is tailored for recognizing coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is adept at triaging hemorrhages from brain CT scans. The company also provides InferRead CT Bone for spotting chest fractures in CT images and InferRead CT Pneumonia for diagnosing and managing pneumonia cases. Beyond these, their offerings extend to InferOperate, which facilitates 3D reconstruction for thoracic, liver, and urological surgical procedures, and InferCare, a tool designed for effective patient management and image follow-up. Additionally, InferScholar acts as an AI-enhanced resource for medical research, further solidifying Infervision's commitment to transforming healthcare through AI technology. This comprehensive suite of solutions positions Infervision as a pivotal player in the evolution of medical practices.

The Montreal Cognitive Assessment (MoCA) is a concise, 30-item evaluation designed for healthcare professionals to identify cognitive deficits at an early stage, facilitating quicker diagnoses and enhanced patient management. This tool enables both healthcare providers and researchers to recognize cognitive challenges associated with various conditions, including Alzheimer's disease, Parkinson's disease, and several others such as frontotemporal dementia and brain tumors. MoCA is frequently utilized by a diverse range of practitioners, including nurses, primary care doctors, specialists, occupational therapists, and psychologists, among others. It efficiently evaluates critical cognitive functions such as short-term memory, visuospatial skills, executive functioning, attention, and language abilities, as well as orientation to time and place. The versatility of MoCA makes it an essential component of cognitive health assessments across various settings.

We are confident that Waveform AI has the potential to significantly enhance the healthcare landscape, and we are developing a platform designed to equip clinicians with essential information and support throughout the entire care continuum. Transforming healthcare truly requires collective effort, and to play our part in advancing the industry, we are publishing peer-reviewed research on AI to illustrate its benefits at every stage of the patient care experience. Our platform aims to assist providers in identifying individuals at high risk for sleep apnea by leveraging data from electronic medical records, waveforms, wearables, and various other sources, facilitating timely referrals for diagnosis. By utilizing this data, we can aid healthcare providers in pinpointing the most critical patients among the vast undiagnosed population, categorizing them based on their risk for adverse outcomes and potential healthcare costs. Additionally, we strive to streamline the diagnostic process for clinicians, enabling them to treat more patients efficiently and effectively by improving the overall quality and speed of sleep apnea diagnoses. In doing so, we hope to foster a healthier future for all patients.

Cardiovascular diseases result in more than 20 million fatalities globally each year, many of which could be avoided through timely detection. Unfortunately, the healthcare sector is often stretched thin, hindered by the limitations of human analysis capabilities. This is where AIATELLA makes a significant impact. Our innovative AI-driven image analysis technology revolutionizes cardiovascular diagnostics. By automating the intricate measurements of blood vessels and leveraging historical data, we substantially reduce the time, expenses, and required expertise, thereby enhancing the potential for vital imaging procedures. AIATELLA's approach not only accelerates the diagnostic process but also boosts the precision and reliability of results, providing critical measurements and disease progression insights in mere seconds rather than hours. As a result of this increased efficiency and accuracy in analyses, healthcare providers can dedicate more time to patient care, ultimately paving the way for effective preventative strategies and personalized treatment options for everyone. This shift could redefine how we approach cardiovascular health on a global scale.

Medgnosis is a cutting-edge application tailored to enhance the interpretation of X-ray images by radiologists. Utilizing sophisticated machine learning techniques, it meticulously analyzes user-selected X-ray images to predict possible abnormalities. This tool serves as an invaluable resource, enriching the diagnostic process with an extra layer of expertise and efficiency. By employing deep learning and neural networks trained on a vast array of data, Medgnosis proficiently detects a diverse range of conditions visible in X-ray scans. Its performance not only rivals but often exceeds traditional diagnostic methods, featuring a system that is continually refined to remain at the leading edge of medical technology. Additionally, Medgnosis produces comprehensive diagnostic reports swiftly, integrating detailed health issue identification, evaluations of severity, and suggested next steps into an easily understandable format. This efficient methodology significantly aids healthcare professionals in making prompt and informed decisions, ultimately enhancing patient care outcomes. Furthermore, the user-friendly interface ensures that even those with limited technical expertise can effectively utilize the application.

Story Health leverages virtual care and advanced AI technology to reconcile clinical data with the real-life experiences of patients, enabling specialists to enhance treatment protocols for those facing severe health challenges. A significant portion of a patient's health journey occurs outside of conventional medical settings, leading to fragmented solutions and lost chances for optimal care, particularly for high-acuity individuals. In response, Story Health presents an innovative approach to managing high morbidity conditions that is more flexible, rapidly deployable, and beneficial for both healthcare providers and patients. This platform equips clinicians with the necessary tools to maintain ongoing connections with patients, oversee complex data flows, and promptly adjust home treatment plans that can have significant impacts on health outcomes. By offering tailored recommendations that reflect the unique circumstances of each patient and align with a clinician's methods, Story Health enhances the ability to monitor patient health between medical appointments. As a result, it becomes simpler to pinpoint patients requiring urgent care, immediate intervention, or adjustments in therapy, thereby improving overall patient management and outcomes. Ultimately, Story Health transforms the way care is delivered, ensuring that no patient is overlooked in their healthcare journey.

Cognistat stands out as a premier cognitive evaluation tool that examines five key areas of cognitive abilities: language, spatial reasoning, memory, calculations, and logical reasoning. Developed at Stanford University, this assessment tool is standardized for use among adolescents, adults, and seniors aged 60 to 84, allowing for broad applicability. It is designed to be administered by healthcare professionals who have received appropriate training. Furthermore, Cognistat has been culturally adapted and validated in various languages through partnerships with esteemed universities, academic institutions, and global clients. Its effectiveness is substantiated by over 400 peer-reviewed scientific studies that document its application in cases involving stroke, dementia, traumatic brain injuries, significant psychiatric conditions, and substance abuse. The Cognistat Assessment System retains the valued features of its traditional paper and pencil version, providing a swift yet thorough evaluation while employing a screening and metric approach to assess cognitive functioning comprehensively. This adaptability and thoroughness make it a vital resource in various clinical settings, enhancing the assessment process for diverse patient populations.

Pearl is an AI-powered dental imaging platform that helps dentists deliver more accurate diagnoses and better patient outcomes. It leverages advanced machine learning and computer vision to analyze 2D and 3D dental x-rays in real time. Pearl enhances radiographic images using AI preprocessing to ensure reliable analysis even when x-rays are unclear or distorted. Its segmentation technology isolates tooth structures and surrounding anatomy to provide localized clinical insight. Detection models identify a wide range of pathologic, restorative, and anatomical features that may otherwise be overlooked. Measurement tools assess the extent of decay and anatomical changes with precision. Pearl integrates smoothly with existing x-ray systems, requiring minimal workflow changes. The platform is supported by one of the world’s largest curated dental radiograph datasets. With proven performance and enterprise-grade reliability, Pearl helps dentists communicate findings more clearly with patients. It is authorized for clinical use across more than 120 countries worldwide.

NeuroQ stands out as a premier software for brain imaging analysis, delivering a robust diagnostic resource applicable across various modalities and clinical scenarios. This comprehensive tool supports an array of imaging techniques, including FDG, Amyloid, SPECT, DaTscan, and Epilepsy, thereby enhancing diagnostic precision in differentiating between various conditions. As one of the most prevalent quantitative instruments utilized in the differential diagnosis of dementia, NeuroQ transcends simple visual evaluations by offering crucial, objective diagnostic insights. It efficiently assesses metabolic levels across over 240 predefined brain regions, contrasting them with a normative database to quantify the extent of abnormalities and their statistical significance. Designed to assist in the evaluation of human brain scans, NeuroQ meticulously quantifies mean pixel values within standardized areas of interest and allows for detailed comparisons with other brain images, ultimately contributing to better patient outcomes. This innovative software is essential for clinicians seeking reliable data to inform their diagnostic processes and treatment decisions.

Our innovative AI solution empowers healthcare practitioners to conduct high-quality ultrasound examinations anytime and anywhere, irrespective of their experience level with ultrasound technology. While ultrasound serves as a reliable and effective diagnostic instrument, mastering its use can be challenging, requiring extensive specialized training and often resulting in variable image quality. The examination process demands precise hand-eye coordination and can be visually unintuitive, complicating the learning curve. Moreover, conventional ultrasound software fails to provide guidance on how to maneuver the ultrasound transducer effectively or offer immediate feedback regarding the clarity of the images obtained. This can lead to subpar imaging, which in turn results in overlooked diagnoses, unnecessary repeat exams, and inconsistent interpretations of the results. Consequently, the full potential and advantages of ultrasound technology have not been completely harnessed. With the advent of our AI-driven technology, any healthcare provider can now effortlessly capture high-quality diagnostic ultrasound images, as the AI assists them throughout each phase of the scanning procedure, ensuring accuracy and efficiency. This advancement not only enhances the diagnostic capabilities of healthcare providers but also promotes better patient outcomes through timely and accurate assessments.

WRDensity supports radiologists in evaluating breast density, promoting consistency in density assessments across their practices. Its primary aim is to facilitate early detection while ensuring patients feel reassured through enhanced consistency, confidence, and overall quality of care. Developed using advanced deep learning techniques, WRDensity analyzed over 600,000 images sourced from the esteemed Mallinckrodt Institute of Radiology, known for its pioneering work in the field. This robust deep learning model excels in providing precise classifications of breast density. Additionally, the batching and sorting features can boost user productivity by as much as 20%. By integrating WRDensity into the radiologist's existing workstation, critical information regarding tissue density is readily accessible in a relevant context, further enhancing the diagnostic process. Ultimately, this innovation not only streamlines the workflow but also contributes to improved patient outcomes.

IntelliSpace Portal 9.0 is an innovative visualization platform encompassing over 70 clinical applications, providing a cohesive solution that enhances speed and efficiency while boosting diagnostic confidence, particularly in the analysis and monitoring of complex cases. As the global population ages, the prevalence of neurodegenerative diseases continues to escalate, necessitating long-term monitoring for patients with neurological disorders, which can often exhibit subtle brain changes that are difficult to identify. To address these challenges, IntelliSpace Portal 9.0 introduces several new and improved neuro applications, including NeuroQuant®¹, LoBi, and CT Brain Perfusion, all designed for swift, objective, and consistent image assessment. Additionally, with a growing focus on pulmonary health, this platform equips you with a comprehensive suite of tools to seamlessly manage pulmonary disease from initial detection through to ongoing follow-up, ultimately aiming to improve patient outcomes. This integration of neuro and pulmonary features positions IntelliSpace Portal 9.0 as a vital resource in modern medical imaging and diagnostics.

Tapt Health streamlines your documentation process during patient treatment. Utilize AI to enhance patient engagement, accelerate evaluations, and reduce the need for after-hours paperwork, allowing you to focus more on care and less on administrative tasks.

NeuroAtHome stands out as the sole rehabilitation software platform tailored explicitly for addressing the consequences of neurological injuries or neurodegenerative conditions. Throughout each rehabilitation session, the platform meticulously tracks the exercises undertaken, assessing both the quality and execution of movements. This allows the healthcare team responsible for patient rehabilitation to objectively monitor their progress over time. Utilizing advanced real-time motion capture technology that requires no wearable devices, along with virtual reality and interactive touch screens, NeuroAtHome offers a comprehensive suite of 80 exercises aimed at physical and cognitive recovery. The platform is versatile enough for use in various environments, including hospitals, clinics, outpatient centers, and even patients' homes. No matter the location, the clinical team can craft and tailor rehabilitation sessions to suit individual patient needs, adjusting future sessions based on the outcomes achieved. This adaptability ensures that each patient's unique journey toward recovery is carefully supported and enhanced.

Volpara Health software is utilized by various facilities, including leading cancer screening centers in the United States, to facilitate the early detection of breast cancer. Mammography technologists depend on this software to enhance the quality of mammograms. Recognized as the most scientifically validated screening tool in the breast health sector, Volpara provides essential evidence at critical moments. It offers access to comprehensive patient data, enabling more accurate assessments of breast cancer risk. Each analyzed image contributes to refining our algorithms for early detection of the disease. Your support is crucial in promoting additional screening or genetic tests for patients. The platform allows for the creation of tailored worklists and reports according to individual preferences. Users can simultaneously view statistics and lists from a single interface, making the process more efficient. Communication can be standardized across patients, referrers, and insurers, ensuring clarity and consistency. Furthermore, it enhances the delivery of result letters by incorporating thumbnail images of mammograms, making the information more engaging and informative. This multifaceted approach ultimately promotes better patient care and outcomes in breast health.

Pearl's innovative platform, powered by artificial intelligence, empowers healthcare teams to cut unnecessary expenses, enhance patient outcomes, and thrive in value-based care by pinpointing priority patients and encouraging timely interventions while seamlessly fitting within existing workflows without causing disruption. This technology merges predictive analytics with effective action; it emphasizes significant outreach and automates subsequent steps, evaluates provider readiness and cohort risk to align participants with suitable payment models, and links intelligence to action to foster measurable advancements in clinical, financial, and operational performance. Moreover, it integrates flawlessly into provider systems, enabling teams to deliver high-quality care on a large scale. The platform's advanced data-science and actuarial capabilities maximize savings, improve benchmarks, and support various models like ACO REACH, MSSP, and Medicare Advantage, all while equipping physicians with user-friendly tools that streamline care delivery, alleviate them from mundane tasks, and enhance management of patient panels. Ultimately, Pearl's solution stands out in the healthcare landscape by prioritizing efficiency and effectiveness in care delivery, ensuring that both providers and patients benefit from its comprehensive features.

Altris AI is an advanced, cloud-based clinical decision support system powered by artificial intelligence, specifically tailored to aid eye care professionals in interpreting OCT scans and making informed decisions. The platform streamlines the identification of pathological OCT scans while recognizing over 70 retina-related pathologies and biomarkers, which include some that are quite uncommon. Features of the system encompass severity detection, analysis of retina layer thickness, layer segmentation, and both automatic and manual measurement capabilities. It is designed to work seamlessly with all OCT devices and accommodates various data formats like DICOM, JPEG, and PNG. Furthermore, Altris AI has received FDA clearance, CE certification, and is compliant with GDPR and HIPAA regulations, thereby upholding rigorous standards for data security and patient confidentiality. By integrating this innovative tool into their practices, eye care professionals can significantly enhance patient triage, improve diagnostic precision, and more effectively track the progression of diseases over time. As a result, the adoption of Altris AI not only streamlines workflows but also elevates the overall quality of patient care in eye health.

Alife’s advanced AI software is designed to enhance clinic operations, leading to better patient outcomes, greater efficiency, and an improved overall experience for patients. The Alife Assist platform is customizable to support clinic staff in making informed decisions based on data analysis. By integrating smoothly with electronic medical records (EMR), Alife’s AI swiftly transforms raw data into practical insights. It also aims to maximize the retrieval of mature oocytes from ovarian stimulation cycles. This suite of products is created to empower all clinic personnel, ensuring that every team member can contribute effectively. Furthermore, it standardizes the embryo grading process while enhancing quality control and record management. Real-time monitoring of clinic key performance indicators (KPIs) boosts operational efficiency, saving valuable time and reducing costs. Research indicates that interpretable machine learning models perform comparably to embryologists when it comes to selecting optimal embryos for IVF transfer, showcasing their potential utility in clinical settings. Additionally, the study highlights that AI-driven insights might assist in fine-tuning the timing of ovulation trigger injections, potentially leading to improved outcomes for patients undergoing IVF treatments. Overall, this innovative approach represents a significant leap forward in reproductive health technology.

Clinithink stands out as a premier technology firm in the healthcare sector, focusing on artificial intelligence solutions that convert unstructured medical information into valuable insights. The company's proprietary CLiX platform leverages Clinical Natural Language Processing (CNLP) to decipher intricate clinical narratives, which empowers healthcare providers to improve both patient outcomes and operational productivity. Clinithink delivers customized solutions across various domains, including life sciences, revenue cycle management, and population health, effectively tackling issues such as identifying patient cohorts, maximizing reimbursement, and monitoring disease progression. With its cutting-edge technology, Clinithink has earned the confidence of top pharmaceutical and healthcare entities globally, establishing its leadership in the realm of healthcare AI and digital health progress. Moreover, the CLiX platform is adept at comprehending a wide array of unique and intricate clinical concepts, including but not limited to certainty, severity, laterality, and temporality, further enhancing its utility in clinical settings. As the demand for innovative healthcare solutions grows, Clinithink remains committed to advancing its technology to meet the evolving needs of the industry.

LabAnalyzer is an innovative platform that utilizes artificial intelligence to make the interpretation of medical lab tests easier and more accessible. Users have the ability to upload their lab results in various formats such as PDF, image, or text, and they receive immediate and precise explanations of their medical information. Thanks to its advanced AI technology, LabAnalyzer offers comprehensive analyses of crucial metrics, identifies potential health concerns for users to discuss with their healthcare providers, and provides translations in several languages. Notable features include the ability to upload PDFs, images, and text with OCR capabilities for extracting text, in-depth AI-generated insights into lab metrics like glucose and cholesterol levels, real-time language translation for reports, and a secure platform that is both user-friendly and budget-friendly, starting at just $5. LabAnalyzer's mission is to empower individuals to gain a clearer understanding of their health data and to facilitate informed healthcare decisions. Additionally, the platform continually enhances its features to ensure users are well-equipped to manage and interpret their medical laboratory results effectively.

Interpret My Results is a user-friendly web application aimed at patients, utilizing artificial intelligence to deliver straightforward interpretations of laboratory results. By removing complex medical terminology, it enables users to grasp their health information more effectively, allowing them to avoid the delay of waiting for a doctor's consultation or the frustration of sifting through unclear online resources. This innovative tool not only enhances patient understanding but also promotes proactive health management.

Clarafi is a pioneering electronic health record (EHR) and medical scribe platform powered by artificial intelligence that revolutionizes the way clinical documentation and chart management are handled. By utilizing sophisticated AI technology, it can decipher handwriting and interpret clinical content to produce structured patient notes, such as SOAP (Subjective, Objective, Assessment, Plan), in as little as 90 seconds, drastically cutting down on the manual labor required for charting and reducing the administrative workload. The platform efficiently captures and organizes vital information like problem lists, comprehensive medication histories, and reviews of systems from both existing documents and clinician inputs, thereby generating a cohesive, EHR-ready medical record that facilitates e-prescribing, coding, and clinical workflows with minimal typing or manual formatting. Clarafi’s AI not only automates mundane tasks, allowing for quicker chart completion, but also enables clinicians to devote more of their time to patient care instead of paperwork, all while integrating effortlessly into existing practice workflows. This innovative solution exemplifies how technology can enhance efficiency in healthcare settings, ultimately leading to improved patient outcomes and satisfaction.

Fedo Vitals: AI-Powered Health Companion to a Better Future. Fedo Vitals is an AI-driven application that revolutionizes how we monitor and predict our health. Fedo Vitals analyses a person's vital signs using a 14-second video recording. It then provides insight into possible health risks and anticipated medical expenses over the next five years. Fedo Vitals uses data driven AI technology to analyze facial cues and lifestyle information. It extracts vital signs such as blood sugar, blood pressure, blood sugar, heart rate and HRV-SDNN. It also determines if the individual is a smoker. It can detect subtle changes in a person's health status, which allows them to take proactive steps to prevent or delay the onset.

BEKhealth provides an innovative clinical research platform, known as the BEKplatform, which leverages artificial intelligence to streamline the extraction, interpretation, and standardization of both structured and unstructured electronic medical record data, encompassing various elements such as lab results, diagnoses, physician notes, pathology reports, and PDFs. This integrated system creates a searchable, longitudinal patient graph designed to assist life sciences and healthcare organizations in swiftly pinpointing protocol-eligible patients while enhancing trial feasibility, site selection, and recruitment processes. By utilizing advanced deep learning techniques and natural language processing, BEKhealth transforms chaotic clinical data into precise, actionable insights, allowing for the generation of sophisticated queries and patient cohorts. This method not only identifies more qualified candidates compared to traditional manual chart reviews but also provides real-time reports and dashboards that facilitate informed decision-making across research networks, ultimately improving the efficiency and effectiveness of clinical trials. The ability to generate these insights in real-time is a game-changer for organizations striving to maximize their research potential.

Our state-of-the-art technology, powered by artificial intelligence (AI), transforms both organized and disorganized healthcare information into a dependable, high-quality, standardized dataset that can be utilized throughout your organization. By facilitating near real-time access to data from various systems, our solutions alleviate the strain of manual data abstraction, enabling your administrative and clinical teams to reclaim valuable time for quality improvement and research endeavors. Our suite of products and services empowers you to gather, assess, and utilize your data effectively, irrespective of the data source, therapeutic area, organizational department, or pre-existing reporting, business intelligence, or analytics tools. Atlas leverages both human knowledge and AI capabilities to streamline the challenging process of uncovering and interpreting patient data for clinical registries. Meanwhile, Cartographer efficiently searches, evaluates, and interprets patient data across multiple platforms, standardizes that information into a uniform format, and offers pertinent data insights. Ultimately, our innovative solutions not only enhance operational efficiency but also support informed decision-making throughout your organization.

Transform your healthcare experience with the revolutionary Soliton® AI, which is powered by 30,000 evidence-based rules and advanced machine learning techniques. By automating various healthcare and care management functions, Soliton® equips you with the tools necessary to thrive in a value-based care environment, offering unmatched capabilities. It efficiently analyzes vast amounts of patient data in real-time, leading to enhancements in both clinical outcomes and financial performance, while also supporting a range of Alternative Payment Models (APMs). The solution boosts the effectiveness of telehealth by forecasting billable codes during patient interactions and predicting future healthcare costs through sophisticated risk stratification models. Furthermore, it provides timely clinical decision support to assist in managing intricate patient populations. Soliton® optimizes the patient journey, facilitating seamless transitions from acute to post-acute care through AI-driven care coordination. Moreover, it identifies care gaps, uncovers service and coding opportunities, and generates tailored patient assessments and personalized care plans, while also enabling the creation of custom cohorts for targeted interventions. As a result, Soliton® not only enhances operational efficiency but also elevates the overall quality of patient care.

CODIJY provides a fast and user-friendly colorization experience. With just a few simple brush strokes, Colorizer Pro can accurately recreate any texture or surface in your selected hues. Its intelligent border detection feature guarantees meticulous color application to intricate details, allowing for a comprehensive restoration of complex historical imagery. The process is straightforward, requiring no complicated layers or controls; you can easily select colors and apply them using intuitive contours and lines in mere moments. Boasting 100 thematic libraries filled with 14,000 carefully curated colors, it helps you find the perfect color combinations effortlessly. Gradients can be utilized to achieve realistic skin tones with a single stroke, mimicking the natural color shifts found in original photographs. Additionally, you can modify color strokes in real-time, adjusting their Hue, Saturation, and Brightness using the advanced HSB Repainting tool. One of CODIJY's standout features is the ability to see the colorization results as you work, making the editing process both dynamic and interactive. This innovative approach enhances your creative workflow while ensuring every detail is beautifully captured.

Zebra's Imaging Analytics Engine processes imaging scans from multiple modalities and conducts automatic analyses of various clinical findings, ensuring efficiency and seamless integration with the radiology workflow. Healthcare providers rely on Zebra-Med to notify them about patients who are at elevated risk for cardiovascular, pulmonary, skeletal, and other health issues. This system enhances preventative care initiatives, supports accurate risk adjustments, and aids in meeting quality benchmarks like MACRA. By utilizing Zebra-Med, healthcare professionals can concentrate their efforts on the most vulnerable patients at critical moments, ultimately leading to reduced expenses and enhanced patient care outcomes. Consequently, this innovative approach not only improves the quality of care provided but also optimizes resource allocation across the healthcare system.

Our platform, designed with regulatory compliance in mind, enhances clinical research by using algorithms to sift through unstructured EMR data to identify life-threatening conditions. We create cutting-edge technologies that broaden access to groundbreaking healthcare solutions through Clinical Trials. Our dedicated team is committed to saving lives by facilitating access to therapeutic innovations that are still being researched. We strongly advocate that every patient should be informed and empowered regarding their potential to engage in clinical trials that could offer significant therapeutic benefits. As a forward-thinking healthcare AI research firm, we have created a computational platform that identifies patients who meet a detailed set of criteria for participation in clinical trials, ensuring that the most suitable candidates are considered for these critical studies. Through our work, we aim to revolutionize the way patients connect with life-changing treatment opportunities.

RLD360™ is a comprehensive AI-powered platform built to support safer, higher-quality healthcare delivery. It brings together provider management, safety and risk management, regulatory compliance, and patient experience in one connected ecosystem. The platform provides leaders with real-time visibility into risk, performance, and outcomes. AI-powered analytics help organisations act sooner to prevent harm and reduce care variability. RLD360™ supports critical functions such as event reporting, root cause analysis, claims management, and safety huddles. Integrated compliance and standards tools help ensure consistent adherence to best practices. Provider management capabilities support credentialing, scheduling, and performance oversight. Patient experience tools capture feedback and support reputation growth. Secure data availability and archiving ensure information is preserved and accessible. Together, these capabilities help healthcare organisations drive efficiency, readiness, and continuous improvement.

Clario’s Image Redact AI efficiently removes sensitive patient identifiers from various media formats, including videos, photos, and PDFs. This cutting-edge solution combines AI-powered de-identification with the vigilant oversight of a skilled quality control (QC) team, ensuring compliance with EU GDPR and other privacy laws. By implementing this technology, organizations can mitigate the risk of significant penalties and potential liabilities stemming from data breaches. Each image undergoes a thorough de-identification process, leveraging our unique AI capabilities alongside comprehensive human visual QC review to confirm that all necessary redactions have been executed. Additionally, all images are securely stored across multiple geographical locations in data centers that conform to the latest security standards and practices. Users can effortlessly access and evaluate their protected videos, photos, and PDFs on any device, making it an invaluable resource for clinical trial research projects, while also enhancing overall data security and accessibility.

We streamline clinical processes, allowing you to prioritize what truly matters: caring for your patients. Integrated within the electronic health record (EHR), Regard thoroughly analyzes the entire patient record, facilitating improved diagnosis and treatment. The effectiveness of Regard has been shown to significantly enhance hospital financial performance, promote patient safety, and increase physician satisfaction. By minimizing coding queries, reducing insurance denials, and cutting down the time spent on chart review, we aim to transform healthcare delivery. We invite you to be part of our vision to provide exceptional healthcare for all. Specifically designed for healthcare providers, Regard optimizes workflow, resulting in a more efficient and satisfying experience with the electronic medical record (EMR). By functioning as an AI co-pilot that integrates seamlessly into the EMR, Regard acts as a virtual medical resident, organizing patient information, proposing new diagnoses, and automating the creation of clinical notes. With Regard, you will have more opportunities to engage in the aspects of medicine you are passionate about, while our technology handles the intricacies of data management. Ultimately, Regard's AI co-pilot is an invaluable tool that enhances both patient care and the physician experience.

Credo Health is an innovative SaaS platform fueled by artificial intelligence, designed to propel the future of value-based healthcare. It empowers physicians, MSOs, ACOs, and health plans to effectively diagnose, document, and treat each patient through a wealth of clinical intelligence. By consolidating disparate patient data, Credo’s platform generates nearly complete longitudinal records seamlessly integrated into existing EHR workflows. Its AI-driven tools facilitate the acquisition of medical records, enhance data analysis, boost patient engagement, and optimize performance. Clinicians receive actionable insights right at the point of care, alleviating additional administrative burdens. Meanwhile, administrators gain access to real-time analytics that enhance risk adjustment precision and quality performance. Ultimately, Credo Health equips healthcare organizations with the means to cut costs, elevate patient outcomes, and function more efficiently within value-based care frameworks, paving the way for a transformative shift in the healthcare landscape. This comprehensive approach not only supports immediate clinical needs but also fosters long-term improvements in healthcare delivery.

WorkDone Health serves as an AI-powered compliance assistant that helps avert minor medical documentation mistakes from escalating into significant financial issues. By seamlessly integrating with hospital electronic health records (EHRs), it continuously tracks clinical activities and employs AI agents to identify and rectify problems—such as overlooked discharge notes or incorrect medication timing—before they lead to claim rejections or audits. When an issue is detected, our AI promptly initiates a dialogue with the relevant staff member to validate and address the matter without delay. Beyond merely providing alerts, WorkDone Health actively resolves issues, enabling clinics and hospitals to enhance patient outcomes, expedite revenue collection, minimize claim denials, and alleviate the workload on clinical teams. This proactive approach not only improves compliance but also fosters a more efficient healthcare environment.

The product evaluates a patient's risk level to create a tailored digital screening plan, ensuring more reliable follow-up recommendations and enhancing diagnostic accuracy. This strategy is particularly effective in identifying cancers in women who are at heightened risk. WRRisk integrates a fully digital breast cancer risk assessment that utilizes patient-completed digital forms alongside a density evaluation to generate a comprehensive risk scorecard. By automating numerous manual processes, such as form collection and letter creation, WRRisk streamlines the management of breast risk programs, eliminating the need for paper documentation. This innovative product empowers both patients and healthcare providers with essential information, enhancing the overall care experience. Additionally, WRRisk provides calculations for ten-year and lifetime risk, as well as assessments based on secondary density metrics.

SubtleMR allows medical facilities to acquire sequences of images more quickly while ensuring excellent diagnostic quality. It employs two key techniques for enhancement: denoising and super resolution, which elevate the quality of rapid MRI scans. As a result, patients can complete their MRI procedures in a shorter time span, enhancing their overall comfort and experience. This improvement enables hospitals and imaging centers to increase their daily patient throughput using the same MRI equipment, effectively boosting scanner capacity and minimizing waiting periods. By streamlining scan protocols and enhancing lower-quality images, SubtleMR mitigates the risk of artifacts and reduces the necessity for repeat scans, addressing common issues faced by both practitioners and patients. Additionally, SubtleMR integrates effortlessly into existing workflows, acting as a bridge between the MRI scanner and the PACS system. The software processes images within seconds after they are captured, ensuring that high-quality images are promptly returned to PACS or other workstations for review. This efficiency not only benefits patient care but also optimizes the overall operational workflow of imaging departments.

Primarily, the nxtHealth Smart Technologies for Telehealth enhances patient care by extending the therapeutic experience beyond traditional clinical environments. The nxtHealth APPS offer continuous care through features that enable measurement, data collection, reporting, and exercise guidance directly on mobile devices. For instance, the nxtHealth WEARBLS work in tandem with the APPS by providing valuable data from wearable sensors. These APPS and WEARBLS are integrated smoothly via a HIPAA-compliant backend, which includes a provider portal equipped with advanced data ANALYTX capabilities. Additionally, nxtHealth enhances the quality of data, communication between patients and providers, and overall care quality through its user-friendly design and seamless integration. Furthermore, nxtHealth comprises a comprehensive array of smart technologies for telehealth aimed at supporting patient-reported outcomes (PRO), cognitive assessments, and rehabilitation efforts, ensuring a holistic approach to patient wellness.

XOresearch has developed an innovative Artificial Intelligence solution for the automatic annotation and analysis of electrocardiograms. This comprehensive tool serves three primary functions: it enhances clinical diagnosis productivity, facilitates remote patient monitoring, and offers readily available software for digital health devices and applications. CardioAI® stands out as a sophisticated productivity enhancer that speeds up the analysis of electrocardiograms, proving particularly beneficial in scenarios requiring continuous or extended cardiac monitoring. Its deployment significantly improves health surveillance capabilities, especially in remote, challenging, or hazardous environments. The system's ability to deliver accurate near real-time processing enables unparalleled medical assistance. Furthermore, CardioAI® can seamlessly integrate into electronic health record (EHR) systems or operate as part of mobile health devices. This commercially available software is versatile enough to be customized to meet various business needs. Additionally, CardioAI® guarantees precise and comprehensive annotation of stress, rest, and Holter electrocardiograms, adhering strictly to the HL7® aECG standard, which ensures consistency and reliability in data interpretation. Its adaptability and efficiency make it an invaluable asset in modern healthcare practices.

Numerous choices in cancer treatment are fraught with uncertainty, and existing resources fail to assist a significant number of patients effectively. As a result, this situation contributes to preventable fatalities and the loss of billions in healthcare expenditures. Our team, which consists of experts from both computer science and oncology, is dedicated to addressing the critical challenges in cancer care using artificial intelligence. We are developing clinical-grade deep learning models that evaluate individual patient profiles and offer valuable guidance to oncologists during their decision-making processes. By placing oncologists at the forefront of our AI development, we ensure that the insights generated are not only interpretable but also actionable. Collaborating with leading academic medical institutions and community oncologists, we aim to tackle important clinical questions to improve patient outcomes. Ultimately, our goal is to enhance decision-making in cancer care and reduce the associated burdens on patients and healthcare systems.

VideaAI is an innovative platform that leverages artificial intelligence to enhance the precision of diagnostics, streamline clinical processes, and boost operational productivity in dental practices by examining dental imaging alongside practice data. Utilizing sophisticated machine learning algorithms that have been developed with extensive datasets of dental images, it is capable of automatically scrutinizing common radiographs, including bitewing and panoramic X-rays, to uncover clinical issues such as cavities, bone degeneration, and other oral health concerns that may not be easily visible to the unaided eye. The platform effectively conveys these clinical findings through intuitive visual overlays and annotations, aiding dentists in communicating diagnoses to patients and fostering a clearer understanding of proposed treatment options. VideaAI seamlessly integrates with current dental imaging systems and practice management tools, providing AI-driven insights in real time at the point of care, all while maintaining the flow of clinical operations. Additionally, by enhancing both diagnostic capabilities and patient engagement, VideaAI positions dental practices for improved outcomes and overall patient satisfaction.